Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4

2(40.0%)

Phase 2

1(20.0%)

N/A

1(20.0%)

Phase 3

1(20.0%)

5Total

Phase 4(2)

Phase 2(1)

N/A(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07570160Phase 4Not Yet Recruiting

Intranasal Dexmedetomidine or Esketamine for Negative Postoperative Behavioral Changes in Children

Role: collaborator

NCT03255694Phase 2Active Not Recruiting

A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature

Role: collaborator

NCT06890143Phase 3Recruiting

The Efficacy and Safety of Dapagliflozin in the Treatment of Hereditary Kidney Disease With Proteinuria in Children

Role: collaborator

NCT06575283Not Yet Recruiting

Predicting Cerebral Palsy in Infants With White Matter Injury Using MRI

Role: collaborator

NCT05206799Unknown

The CMCPCTH Research in Chinese Children

Role: collaborator

NCT03453502Not ApplicableCompleted

Improving Mother Milk Feeding Benefits in Neonatal Intensive Care Units

Role: collaborator

NCT03791827Unknown

Multicenter Registry of Pediatric Lupus Nephritis in China

Role: collaborator

NCT03249480Phase 4Unknown

Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency

Role: collaborator

All 8 trials loaded